Instructions forNootropil (Piracetam) pills
English product name
Nootropil®
Release form
p-r d/ingestion 200 mg/1 ml: fl 125 ml w/cup
tab, outer sheath, 800 mg: 30 pcs
tab, shell, 1200 mg: 20 pcs.
Description
- The infusion solution is colorless, transparent.
1 ml
piracetam 200 mg
Auxiliary substances: glycerol 85% 27 g, sodium saccharinate 300 mg, sodium acetate 200 mg, methylparahydroxybenzoate 135 mg, propyl parahydroxybenzoate 15 mg, aromatizator apricot 30 mg, caramel aromatizator 15 mg, ice acetic acid 16 mg±5%, water purified 62.1 g±5%.
125 ml - bottles of dark glass (1) complete with measuring cup - cardboard packs.
ATC codes Nootropil
N06BX03 Piracetam
Clinical-pharmacological groups / Group affiliation
Nootropic preparation
Active substance
piracetam
Pharmacotherapy group Piracetam:
Nootropic agent
Storage Conditions Piracetam
The drug should be stored in a dry place not accessible to children at a temperature not higher than 25 ° C.
Testimony Nootropil:
Adults
- symptomatic treatment of psychoorganic syndrome, in particular, in elderly patients, accompanied by memory loss,
- dizziness,
- reduced concentration of attention and activity, mood change, behavior disorder, gait disorders (these symptoms may be
- early signs of age-related diseases such as Alzheimer's disease and Alzheimer's senile dementia);
- Treatment of dizziness and related imbalance, except for vasomotor and psychogenic dizziness;
- Treatment of dyslexia (as part of complex therapy);
- prevention of sickle cell vasoocclusive crease.
- Children
- Treatment of dyslexia (as part of complex therapy);
Method of use, course and dosage Nootropil:
The drug is administered inwards, during meals or on an empty stomach, sucking with liquid.
Symptomatic treatment of psychoorganic syndrome: 2.4-4.8 g/day in two or three receptions.
Treatment of dizziness and related imbalance: 2.4-4.8 g/day in 2-3 reception.
Treatment of cortical myoclonia starts at a dose of 7.2 g/day, every three to four days the dose is increased by 4.8 g/day to reach a maximum dose of 24 g/day in 2-3 doses. Treatment continues throughout the disease. Every 6 months, attempts should be made to reduce the dose or cancel the drug, gradually reducing the dose by 1.2 g/day every two days.
Pharmacological effect Nootropil:
Nootropic drug, a cyclic derivative of gamma-aminobutyric acid (GABA).
Evidence suggests that the underlying mechanism of action of piracetam is not cell-specific or organospecific.
- Nosology (ICD codes)
- D57
- Sickle cell disorders
- F01
- Vascular dementia
- F07
- Personality and behavioural disorders caused by disease, damage or brain dysfunction
- F80
- Specific disorders of speech and language development
- G25.3
- Myoclonus
- I67.2
- Cerebral atherosclerosis
- I69
- Effects of cerebrovascular disease
- R42
- Dizziness and disturbance of stability
